Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro

Fig. 1

Experimental protocol of MSC-CM treatment on BV2 cells. MSCs were primed with IL-1α, and the CM used on BV2 cells (treated or not with LPS). Summary of experimental conditions: 1, MSC-CM; 2, primed MSC-CM; 3, untreated BV2; 4, BV2 treated with LPS; 5, BV2 treated with MSC-CM; 6, BV2 treated with primed MSC-CM; 7, BV2 treated with LPS and MSC-CM; 8, BV2 treated with LPS and primed MSC-CM. hMSC human mesenchymal stem/stromal cell, IL interleukin, LPS lipopolysaccharide

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512